Fulcrum Therapeutics, Inc. (FULC)
NASDAQ: FULC · Real-Time Price · USD
3.700
+0.200 (5.71%)
At close: Jun 18, 2026, 4:00 PM EDT
3.667
-0.034 (-0.91%)
After-hours: Jun 18, 2026, 7:15 PM EDT
Fulcrum Therapeutics Employees
Fulcrum Therapeutics had 55 employees as of December 31, 2025. The number of employees increased by 10 or 22.22% compared to the previous year.
Employees
55
Change (1Y)
10
Growth (1Y)
22.22%
Revenue / Employee
n/a
Profits / Employee
-$1,383,927
Market Cap
246.54M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 55 | 10 | 22.22% |
| Dec 31, 2024 | 45 | -31 | -40.79% |
| Dec 31, 2023 | 76 | -13 | -14.61% |
| Dec 31, 2022 | 89 | -15 | -14.42% |
| Dec 31, 2021 | 104 | 31 | 42.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Fate Therapeutics | 161 |
| Codexis | 146 |
| Adagene | 128 |
| AC Immune | 122 |
| Foghorn Therapeutics | 106 |
| Orchestra BioMed Holdings | 86 |
| Cybin | 50 |
FULC News
- 16 days ago - Fulcrum Therapeutics downgraded to Underweight from Overweight at JPMorgan - TheFly
- 16 days ago - Goldman suspends rating on Fulcrum Therapeutics - TheFly
- 16 days ago - Fulcrum Therapeutics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information about Potentially Recovering Their Losses - GlobeNewsWire
- 16 days ago - Fulcrum Therapeutics price target lowered to $3 from $8 at BofA - TheFly
- 16 days ago - Fulcrum plummets 50% after scrapping lead sickle-cell drug on FDA concerns - Reuters
- 16 days ago - Fulcrum Therapeutics downgraded to Market Perform from Outperform at Leerink - TheFly
- 16 days ago - Fulcrum Therapeutics downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 16 days ago - Fulcrum Therapeutics downgraded to Market Perform from Outperform at Leerink - TheFly